Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease

NCT03909646 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Bowen's Disease

Interventions

DRUG: Methyl Aminolevulinate (Mal) for Topical Administration, 16.8%, 1 Gram
DRUG: 5Fluorouracil
OTHER: Surgical excision

Sponsor

Maastricht University Medical Center